辅助生殖时代的抗精子抗体与自身免疫
男性因素不孕约占不孕病例的一半,抗精子抗体(ASA)影响5%-12%的不育男性。ASA主要由血睾屏障破坏后免疫原性精子抗原暴露引起,以IgG和IgA为主,损害精子活力、宫颈黏液穿透和配子相互作用。诊断主要依靠混合抗球蛋白反应和免疫珠试验,当代指南不推荐普遍筛查,仅用于不明原因不孕或孤立性弱精症等灰色地带。治疗上全身免疫抑制已被放弃,低水平抗体结合可行宫腔内人工授精(IUI),高水平自身免疫(>80%)则需卵胞浆内单精子注射(ICSI)绕过免疫屏障。
要点
- ASA影响5%-12%不育男性,主要因血睾屏障破坏暴露精子抗原所致。
- 当代指南不推荐常规ASA筛查,仅用于不明原因不孕或孤立性弱精症。
- 高水平精子自身免疫(>80%)时IUI无效,需ICSI机械 bypass 免疫屏障。
核心结论
- ASA检测已从常规筛查转变为靶向分诊工具,治疗按自身免疫程度分层,高水平结合需ICSI。
研究设计与样本
- 本文为观点与综述文章,总结ASA病理生理和诊断方法的当前证据。
主要发现
- 男性因素不孕约占不孕病例的一半,ASA影响5%-12%不育男性。
- ASA主要为IgG和IgA类,通过损害精子活力、宫颈黏液穿透和配子相互作用影响生育。
- 诊断主要依靠混合抗球蛋白反应和免疫珠试验等直接检测法。
关键数值与推荐
- 当代指南不推荐普遍ASA检测,保留给不明原因不孕或孤立性弱精症等灰色地带。
- 低水平抗体结合时IUI仍可行,高水平精子自身免疫(>80%)时IUI无效,需ICSI。
- 历史性全身免疫抑制因无效和不良反应已被基本放弃。
临床怎么用
- 对不明原因不孕或孤立性弱精症患者可考虑ASA检测以指导IUI与IVF决策。
- 根据抗体结合水平分层:低水平可选IUI,高水平(>80%)直接推荐ICSI。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Male factor infertility acts as a contributing or sole cause in approximately half of all infertility cases, with autoimmunity against spermatozoa-manifested as antisperm antibodies (ASA)-affecting 5%-12% of infertile men. The ASA formation typically results from a disruption of the blood-testis barrier because of trauma, obstruction, or inflammation, leading to the exposure of immunogenic sperm antigens to the systemic immune system. These antibodies, predominantly of the immunoglobulin G and immunoglobulin A classes, impair fertility by hindering sperm motility, preventing cervical mucus penetration, and blocking gamete interaction. Diagnostic evaluation primarily relies on direct assays such as the mixed antiglobulin reaction and immunobead test; however, in the era of intracytoplasmic sperm injection, the utility of ASA testing has evolved from routine screening to a targeted triage tool. Contemporary guidelines discourage universal testing, reserving it for ‟gray zone" clinical scenarios, such as unexplained infertility or isolated asthenozoospermia, where results directly influence the decision between intrauterine insemination (IUI) and in vitro fertilization. Therapeutically, historical reliance on systemic immunosuppression has been largely abandoned because of inefficacy and adverse effects. Instead, management is now stratified by the degree of autoimmunity: although IUI remains a viable option for lower levels of antibody binding, high levels of sperm autoimmunization (>80%) render IUI ineffective, necessitating intracytoplasmic sperm injection to mechanically bypass the immune barrier. This views and reviews article summarizes current evidence on pathophysiology and diagnostic methodologies, providing a pragmatic, management-oriented algorithm to guide urologists and reproductive specialists in optimizing outcomes for couples with immunologic infertility.
引用
- Mass Lindenbaum M, Kuribayashi S, Lundy SD, et al. Antisperm antibodies and autoimmunity in the era of assisted reproduction. Fertil Steril. 2026. PMID: 41812699. doi:10.1016/j.fertnstert.2026.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。